安車檢測(300572.SZ)大股東雲南智輝減持期誤操買入4200股
格隆匯3月2日丨安車檢測(300572.SZ)公佈,2020年3月2日,公司大股東雲南智輝通過集中競價方式減持2.99萬股;在實施減持公司股份操作時,由於操作人員失誤,將“賣出”指令誤操作成“買入”,通過集中競價方式錯誤委託買入公司股票共計4200股,公司瞭解其誤操作後,立即叫其停止交易。
雲南智輝在公司預披露減持計劃之後,所有交易均為賣出,本次屬於誤操作買入公司股票。本次誤操作買入公司股票數量為4200股,其買入均價為48.070元/股,其當天賣出均價為48.071元/股,交易收益4.2元,並將其交易收益上交公司。截至目前,雲南智輝合計持有公司2308.83萬股,佔總股本的11.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.